Capillary Biomedical, Inc.
Reinforced infusion set catheter cannula with integrated coil and multi-port design for continuous subcutaneous insulin infusion (CSII)
- Sector
- Medtech
- Headquarters
- IRVINE, CA
- Founded
- 2014
- Latest Form D
- $2.9M, Aug 2018
- Total capital
- $5.3M
- Federal grants
- $2.3M
- 4 awards · 2016–2018
- Rank in peer group#497 of 538
- Private capital raised
- $3M
- 2 Form D · last Aug 2018
- 99 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 5 pending · first 2019
- Rank in peer group#111 of 538
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$2.9M
- Federal grantHealth and Human S · Phase II · Relative Bioavailability of Subcutaneous Insulin over Extended Durations of Infusion Set Use$1.8M
- Federal grantHealth and Human S · Phase I · Multi-Orifice Continuous Subcutaneous Insulin Infusion Catheter with Reduced Pharmacokinetic Variability and Rapid On-Off Pharmacodynamic Actions$45K
- Federal grantHealth and Human S · Phase I · Multi Orifice Continuous Subcutaneous Insulin Infusion Catheter with Reduced Pharmacokinetic Variability and Rapid On Off Pharmacodynamic Actions$269K
- Federal grantHealth and Human S · Phase I · Multi-Orifice Continuous Subcutaneous Insulin Infusion Catheter with Reduced Pharmacokinetic Variability and Rapid On-Off Pharmacodynamic Actions$224K
- Private capital raisedForm D · SEC · 1st filing$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#111 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Paul StrasmaResearcherExecutive Officer, DirectorLinked by $2.3M in grants as PI
- Bruce FeuchterExecutive OfficerNamed in SEC Form D filings
- Howard MirowitzDirectorNamed in SEC Form D filings
- Remmert LaanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 10- GrantedLinear Insertion Device With Rotational DriveUSPTOUS 12,357,751
- GrantedInsulin Infusion SetUSPTOUS 12,214,159
- GrantedSystem For Delivering Fluid To A User TranscutaneouslyUSPTOUS 12,048,828
Show all 10 patent records
- Linear Insertion Device With Rotational DriveJul 15, 2025 · US 12,357,751Granted
- Insulin Infusion SetFeb 4, 2025 · US 12,214,159Granted
- System For Delivering Fluid To A User TranscutaneouslyJul 30, 2024 · US 12,048,828Granted
- Event-driven Compensated Insulin Delivery Over TimeAug 3, 2023 · Application 18011060Pending
- Helical Insertion Infusion DeviceMar 15, 2022 · US 11,273,255Granted
- Helical Insertion Infusion DeviceSep 17, 2019 · US 10,413,658Granted
- Event-driven Compensated Insulin Delivery Over TimeApplication PCTUS2021038028Pending
- Insulin Infusion SetApplication PCTUS2021048015Pending
- Linear Insertion Device With Rotational DriveApplication PCTUS2019060602Pending
- Helical Insertion Infusion DeviceApplication PCTUS2018025712Pending
Related companies, and why
- Paratus DiagnosticsSimilar federal contract value in Medtech · null in contracts
- LIFE MAGNETICS, INC.Similar federal contract value in Medtech · null in contracts
- CAIRNSURGICAL, INC.Similar federal contract value in Medtech · null in contracts
- NOVUSON SURGICAL, INC.Similar federal contract value in Medtech · null in contracts
- THERMIMAGE, INC.Similar federal contract value in Medtech · null in contracts
- CNINE BIOSOLUTIONS, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .